We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Hypothesis of First North America Population Updated by Mitochondrial Genome Analysis

By LabMedica International staff writers
Posted on 26 Jul 2010
Print article
The first arrival humans of North America from Asia is thought to have occurred approximately 15,000-18,000 years ago, however, estimations of the genetic diversity of the first settlers have remained inaccurate. In a new study, researchers have discovered that the diversity of the first Americans has been considerably underestimated, emphasizing the importance of a detailed sampling for accurate analysis of human migrations.

Evidence suggests that humans first crossed into North America from Asia over a land bridge called Beringia, connecting eastern Siberia and Alaska. Genetic studies have provided clues into the initial lineages that entered North America, differentiating the earliest Native American groups from those that arrived later. However, a precise depiction of the number of initial migratory events and routes has been obscure due to incomplete analysis.

In this new project, published online ahead of print on June 29, 2010, in the journal Genome Research, an international group of researchers coordinated by Dr. Antonio Torroni, of the University of Pavia (Italy), performed a comprehensive mitochondrial genome analysis of a poorly characterized lineage known as C1d. Mitochondrial DNA (mtDNA) is passed down through the maternal lineage, and mtDNA sequence markers are very useful tools for mapping ancestry. Similar to other haplogroups that were among the first to arrive in North America, C1d is distributed throughout the continent, suggesting that it may have been also present in the initial founding populations. However, C1d has not been well represented in earlier genetic studies, and the estimated age of about 7,000 years, much younger than the other founding haplogroups, was in all probability inaccurate.

To resolve these inconsistent lines of evidence, the group sequenced and analyzed 63 C1d mtDNA genomes from throughout the Americas. This high-resolution study not only validated that C1d was one of the founding lineages in North America 15,000-18,000 years ago, but revealed another critical insight. "These first female American founders carried not one but two different C1d genomes,” said Ugo Perego, from the Sorenson Molecular Genealogy Foundation (Salt Lake City, UT, USA), and primary author of the study, "thus further increasing the number of recognized maternal lineages from Beringia.”

These study's findings increase the number of founding maternal lineages in North America to 15. Furthermore, this work emphasizes the vital need for a thorough analysis of applicable populations to compile a complete picture of migratory events. Dr. Alessandro Achilli of the University of Perugia (Italy), a coauthor of the report, suggests that the number of distinct mitochondrial genomes that passed from Asian into North America is probably much higher. "These yet undiscovered maternal lineages will be identified within the next three to four years,” Dr. Achilli noted, "when the methodological approach that we used in our study will be systematically applied.”

Scientists involved in the project were from the Sorenson Molecular Genealogy Foundation, the University of Pavia (Pavia, Italy), the University of Perugia (Perugia, Italy), the University of Santiago de Compostela (Santiago de Compostela, Spain), Innsbruck Medical University (Innsbruck, Austria), and the University of Buenos Aries (Buenos Aires, Argentina).

Related Links:

University of Pavia
Sorenson Molecular Genealogy Foundation



Gold Member
Hematology Analyzer
Swelab Lumi
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Cortisol Rapid Test
Finecare Cortisol Rapid Quantitative Test
New
Hepato Fibrosis Assays
Hepato Fibrosis Assays

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.